T-cell apoptosis in human glioblastoma multiforme: Implications for immunotherapy

Journal of Neuroimmunology

Volumn 175, Issue 1-2, 2006, Pages 59-68

  Walker, David G ^a,b,c   Chuah, Teong ^b,c   Rist, Michael J ^b   Pender, Michael P ^b  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Apoptosis; Fas (CD95); Glioblastoma; T cell; Tumour

Indexed keywords

CD3 ANTIGEN; FAS ANTIGEN; FAS LIGAND; GLIAL FIBRILLARY ACIDIC PROTEIN; LIPOCORTIN 5; PROPIDIUM IODIDE; T LYMPHOCYTE RECEPTOR;

APOPTOSIS; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; FLOW CYTOMETRY; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; LYMPHOCYTE; NICK END LABELING; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING; T LYMPHOCYTE;

APOPTOSIS; FLOW CYTOMETRY; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; IN SITU NICK-END LABELING; LYMPHOCYTES, TUMOR-INFILTRATING; T-LYMPHOCYTES;

EID: 33646879823     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2006.03.006     Document Type: Article

References (49)

1. Bertrand I., and Mannen H. Etudes des reactions vasculaires dans les astrocytomes. Rev. Neurol. (Paris) 102 (1960) 3-9
2. Black K.L., Chen K., Becker D.P., and Merrill J.E. Inflammatory leukocytes associated with increased immunosuppression by glioblastoma. J. Neurosurg. 77 (1992) 120-126
3. Brooks W.H., Markesbery W.R., Gupta G.D., and Roszman T.L. Relationship of lymphocyte invasion and survival of brain tumor patients. Ann. Neurol. 4 (1978) 219-224
4. Brunner T., Mogil R.J., LaFace D., Yoo N.J., Mahboubi A., Echeverri F., Martin S.J., Force W.R., Lynch D.H., and Ware C.F. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373 (1995) 441-444
5. Chahlavi A., Rayman P., Richmond A.L., Biswas K., Zhang R., Vogelbaum M., Tannenbaum C., Barnett G., and Finke J.H. Glioblastomas induce T-lymphocyte death by two distinct pathways involving gangliosides and CD70. Cancer Res. 65 (2005) 5428-5438
6. Dhein J., Walczak H., Baumler C., Debatin K.M., and Krammer P.H. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373 (1995) 438-441
7. Didenko V.V., Ngo H.N., Minchew C., and Baskin D.S. Apoptosis of T lymphocytes invading glioblastomas multiforme: a possible tumor defense mechanism. J. Neurosurg. 96 (2002) 580-584
8. Dix A.R., Brooks W.H., Roszman T.L., and Morford L.A. Immune defects observed in patients with primary malignant brain tumors. J. Neuroimmunol. 100 (1999) 216-232
9. Gehrmann J., Matsumoto Y., and Kreutzberg G.W. Microglia: intrinsic immuneffector cell of the brain. Brain Res. Brain Res. Rev. 20 (1995) 269-287
10. Gold R., Schmied M., Giegerich G., Breitschopf H., Hartung H.P., Toyka K.V., and Lassmann H. Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab. Invest. 71 (1994) 219-225
11. Groux H., Monte D., Plouvier B., Capron A., and Ameisen J.C. CD3-mediated apoptosis of human medullary thymocytes and activated peripheral T cells: respective roles of interleukin-1, interleukin-2, interferon-gamma and accessory cells. Eur. J. Immunol. 23 (1993) 1623-1629
12. Hahne M., Rimoldi D., Schroter M., Romero P., Schreier M., French L.E., Schneider P., Bornand T., Fontana A., Lienard D., Cerottini J., and Tschopp J. Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape. Science 274 (1996) 1363-1366
13. Heesters M.A., Koudstaal J., Go K.G., and Molenaar W.M. Analysis of proliferation and apoptosis in brain gliomas: prognostic and clinical value. J. Neurooncol. 44 (1999) 255-266
14. Husain N., Chiocca E.A., Rainov N., Louis D.N., and Zervas N.T. Co-expression of Fas and Fas ligand in malignant glial tumours and cell lines. Acta Neuropathol. (Berl) 95 (1998) 287-290
15. Ju S.T., Panka D.J., Cui H., Ettinger R., el-Khatib M., Sherr D.H., Stanger B.Z., and Marshak-Rothstein A. Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373 (1995) 444-448
16. Kleihues P., Burger P.C., and Scheithauer B. Histological Typing of Tumors of the Central Nervous System (1993), Springer-Verlag
17. Korshunov A., Golanov A., Sycheva R., and Pronin I. Prognostic value of tumour associated antigen immunoreactivity and apoptosis in cerebral glioblastomas: an analysis of 168 cases. J. Clin. Pathol. 52 (1999) 574-580
18. Kuriyama H., Lamborn K.R., O'Fallon J.R., Iturria N., Sebo T., Schaefer P.L., Scheithauer B.W., Buckner J.C., Kuriyama N., Jenkins R.B., and Israel M.A. Prognostic significance of an apoptotic index and apoptosis/proliferation ratio for patients with high-grade astrocytomas. Neuro-oncology 4 (2002) 179-186
19. Leung S.Y., Wong M.P., Chung L.P., Chan A.S., and Yuen S.T. Monocyte chemoattractant protein-1 expression and macrophage infiltration in gliomas. Acta Neuropathol. (Berl) 93 (1997) 518-527
20. Liu Y., and Janeway Jr. C.A. Interferon gamma plays a critical role in induced cell death of effector T cell: a possible third mechanism of self-tolerance. J. Exp. Med. 172 (1990) 1735-1739
21. Magnus T., Chan A., Savill J., Toyka K.V., and Gold R. Phagocytotic removal of apoptotic, inflammatory lymphocytes in the central nervous system by microglia and its functional implications. J. Neuroimmunol. 130 (2002) 1-9
22. Mahaley Jr. M.S., Bigner D.D., Dudka L.F., Wilds P.R., Williams D.H., Bouldin T.W., Whitaker J.N., and Bynum J.M. Immunobiology of primary intracranial tumors. Part 7: active immunization of patients with anaplastic human glioma cells: a pilot study. J. Neurosurg. 59 (1983) 201-207
23. Mantovani A., Bottazzi B., Colotta F., Sozzani S., and Ruco L. The origin and function of tumor-associated macrophages. Immunol. Today 13 (1992) 265-270
24. Miyagi K., Ingram M., Techy G.B., Jacques D.B., Freshwater D.B., and Sheldon H. Immunohistochemical detection and correlation between MHC antigen and cell-mediated immune system in recurrent glioma by APAAP method. Neurol. Med. Chir. (Tokyo) 30 (1990) 649-655
25. Nakamizo A., Inamura T., Ikezaki K., Yoshimoto K., Inoha S., Mizoguchi M., Amano T., and Fukui M. Enhanced apoptosis in pilocytic astrocytoma: a comparative study of apoptosis and proliferation in astrocytic tumors. J. Neuro-oncol. 57 (2002) 105-114
26. Nakamura M., Konishi N., Tsunoda S., Hiasa Y., Tsuzuki T., Inui T., and Sakaki T. Retinoblastoma protein expression and MIB-1 correlate with survival of patients with malignant astrocytoma. Cancer 80 (1997) 242-249
27. Nguyen K.B., and Pender M.P. Phagocytosis of apoptotic lymphocytes by oligodendrocytes in experimental autoimmune encephalomyelitis. Acta Neuropathol. (Berl) 95 (1998) 40-46
28. Ni K., and O'Neill H.C. The role of dendritic cells in T cell activation. Immunol. Cell Biol. 75 (1997) 223-230
29. O'Connell J., O'Sullivan G.C., Collins J.K., and Shanahan F. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J. Exp. Med. 184 (1996) 1075-1082
30. Palma L., Di Lorenzo N., and Guidetti B. Lymphocytic infiltrates in primary glioblastomas and recidivous gliomas. Incidence, fate, and relevance to prognosis in 228 operated cases. J. Neurosurg. 49 (1978) 854-861
31. Parney I.F., Hao C., and Petruk K.C. Glioma immunology and immunotherapy. Neurosurgery 46 (2000) 778-791
32. Pender M.P. Activation-induced apoptosis of autoreactive and alloreactive T lymphocytes in the target organ as a major mechanism of tolerance. Immunol. Cell Biol. 77 (1999) 216-223
33. Pender M.P., and Rist M.J. Apoptosis of inflammatory cells in immune control of the nervous system: role of glia. Glia 36 (2001) 137-144
34. Pender M.P., McCombe P.A., Yoong G., and Nguyen K.B. Apoptosis of αβ T lymphocytes in the nervous system in experimental autoimmune encephalomyelitis: its possible implications for recovery and acquired tolerance. J. Autoimmun. 5 (1992) 401-410
35. Prins R.M., Graf M.R., and Merchant R.E. Cytotoxic T cells infiltrating a glioma express an aberrant phenotype that is associated with decreased function and apoptosis. Cancer Immunol. Immunother. 50 (2001) 285-292
36. Rhodes R.H. Biological evaluation of biopsies from adult cerebral astrocytomas: cell-growth/cell-suicide ratios and their relationship to patient survival. J. Neuropathol. Exp. Neurol. 57 (1998) 746-757
37. Ridley A., and Cavanagh J.B. Lymphocytic infiltration in gliomas: evidence of possible host resistance. Brain 94 (1971) 117-124
38. Roggendorf W., Strupp S., and Paulus W. Distribution and characterization of microglia/macrophages in human brain tumors. Acta Neuropathol. (Berl) 92 (1996) 288-293
39. Rossi M.L., Hughes J.T., Esiri M.M., Coakham H.B., and Brownell D.B. Immunohistological study of mononuclear cell infiltrate in malignant gliomas. Acta Neuropathol. (Berl) 74 (1987) 269-277
40. Saas P., Walker P.R., Hahne M., Quiquerez A.L., Schnuriger V., Perrin G., French L., Van Meir E.G., de Tribolet N., Tschopp J., and Dietrich P.Y. Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?. J. Clin. Invest 99 (1997) 1173-1178
41. Saito T., Tanaka R., Yoshida S., Washiyama K., and Kumanishi T. Immunohistochemical analysis of tumour-infiltrating lymphocytes and major histocompatibility antigens in human gliomas and metastatic brain tumors. Surg. Neurol. 29 (1988) 435-442
42. Schiffer D., Croveri G., and Pautasso C. Frequency and significance of lymphoplasmocyte infiltration in human gliomas (author's transl). Tumouri 60 (1974) 177-184
43. Schiffer D., Cavalla P., Migheli A., Chio A., Giordana M.T., Marino S., and Attanasio A. Apoptosis and cell proliferation in human neuroepithelial tumors. Neurosci. Lett. 195 (1995) 81-84
44. Strand S., Hofmann W.J., Hug H., Muller M., Otto G., Strand D., Mariani S.M., Stremmel W., Krammer P.H., and Galle P.R. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells - a mechanism of immune evasion?. Nat. Med. 2 (1996) 1361-1366
45. + encephalitogenic T cells. Eur. J. Immunol. 24 (1994) 2609-2617
46. Theele D.P., and Streit W.J. A chronicle of microglial ontogeny. Glia 7 (1993) 5-8
47. von Hanwehr R.I., Hofman F.M., Taylor C.R., and Apuzzo M.L. Mononuclear lymphoid populations infiltrating the microenvironment of primary CNS tumors. Characterization of cell subsets with monoclonal antibodies. J. Neurosurg. 60 (1984) 1138-1147
48. White C.A., McCombe P.A., and Pender M.P. The roles of Fas, Fas ligand and Bcl-2 in T cell apoptosis in the central nervous system in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 82 (1998) 47-55
49. Young H.F., Sakalas R., and Kaplan A.M. Inhibition of cell-mediated immunity in patients with brain tumours. Surg. Neurol. 5 (1976) 19-23